ChiCTR2400094310 版本V1.0 版本创建时间2024/12/19 17:42:48 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2400094310 

最近更新日期:

Date of Last Refreshed on:

2024-12-19 17:42:41 

注册时间:

Date of Registration:

2024-12-19 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

衍射型三焦点人工晶体TFNT00植入术后白内障患者视觉效果及满意度

Public title:

Visual effects and satisfaction of cataract patients after implantation of diffractive trifocal intraocular lens TFNT00

注册题目简写:

English Acronym:

研究课题的正式科学名称:

衍射型三焦点人工晶体TFNT00植入术后白内障患者视觉效果及满意度

Scientific title:

Visual effects and satisfaction of cataract patients after implantation of diffractive trifocal intraocular lens TFNT00

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

胡宗莉 

研究负责人:

胡宗莉 

Applicant:

Zongli Hu 

Study leader:

Zongli Hu 

申请注册联系人电话:

Applicant telephone:

+86 156 8378 3071

研究负责人电话:

Study leader's telephone:

+86 23 68746620

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

hxyyhzl@163.com

研究负责人电子邮件:

Study leader's E-mail:

15683783071@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

重庆市渝中区长江支路10号

研究负责人通讯地址:

重庆市渝中区长江支路10号陆军特色医学中心

Applicant address:

Army Medical Center of PLA, No. 10 Changjiang Branch Road, Yuzhong District, Chongqing

Study leader's address:

Army Medical Center of PLA, No. 10 Changjiang Branch Road, Yuzhong District, Chongqing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

中国人民解放军陆军特色医学中心

Applicant's institution:

Army Medical Center Of PLA

研究负责人所在单位:

中国人民解放军陆军特色医学中心

Affiliation of the Leader:

Army Medical Center of PLA

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

医研伦审(2024)第361号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

中国人民解放军陆军特色医学中心伦理委员会

Name of the ethic committee:

Ethics Committee of Army Medical Center of PLA

伦理委员会批准日期:

Date of approved by ethic committee:

2024-12-09 00:00:00

伦理委员会联系人:

王晶晶

Contact Name of the ethic committee:

Jingjing Wang

伦理委员会联系地址:

重庆市渝中区长江支路10号陆军特色医学中心

Contact Address of the ethic committee:

Army Medical Center of PLA, No. 10 Changjiang Branch Road, Yuzhong District, Chongqing

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 23 68757140

伦理委员会联系人邮箱:

Contact email of the ethic committee:

wii1017@163.com

研究实施负责(组长)单位:

中国人民解放军陆军特色医学中心

Primary sponsor:

Army Medical Center of PLA

研究实施负责(组长)单位地址:

重庆市渝中区长江支路10号陆军特色医学中心

Primary sponsor's address:

Army Medical Center of PLA, No. 10 Changjiang Branch Road, Yuzhong District, Chongqing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

重庆

市(区县):

Country:

China

Province:

Chongqing

City:

单位(医院):

中国人民解放军陆军特色医学中心

具体地址:

重庆市渝中区长江支路10号陆军特色医学中心

Institution
hospital:

Army Medical Center of PLA

Address:

Army Medical Center of PLA, No. 10 Changjiang Branch Road, Yuzhong District, Chongqing

经费或物资来源:

自选课题(自筹)

Source(s) of funding:

Self-selected project (self-funded)

Target disease:

Cataract

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

横断面 

Study design:

Cross-sectional 

研究目的:

本回顾性横断面研究主要对衍射型三焦点人工晶体TFNT00植入术后患者的全程视力、离焦曲线、主观满意度及影响视觉效果的主要原因等进行分析,评估TFNT00人工晶体在白内障患者中的应用效果。  

Objectives of Study:

To analyze the overall visual acuity, defocus curve, subjective satisfaction, and main reasons affecting visual effects of patients after implantation of diffractive trifocal intraocular lens TFNT00, and to evaluate the application effect of TFNT00 intraocular lens in cataract patients.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.行白内障手术并植入TFNT00人工晶体的患者;

Inclusion criteria

1.Patients underwent cataract surgery with TFNT00 intraocular lens implantation.

排除标准:

1.角膜疾病如圆锥角膜、高散光如300度以上或不规则散光,角膜营养不良、变性、瘢痕及斑翳等。 2.晶体脱位、假性剥脱综合征。 3.眼部合并症如葡萄膜炎、青光眼、玻璃体积血、视网膜脱离、视网膜血管阻塞、糖尿病视网膜病变、黄斑水肿等。 4.既往眼外伤史或内眼手术史。 5.系统性疾病有手术禁忌症者,失访。

Exclusion criteria:

1.Corneal diseases such as keratoconus, high astigmatism above 300 degrees or irregular astigmatism, corneal malnutrition, degeneration, scars, and opacities. 2.Lens dislocation, pseudodetachment syndrome. 3.Ocular complications such as uveitis, glaucoma, vitreous hemorrhage, retinal detachment, retinal vascular occlusion, diabetes retinopathy, macular edema, etc. 4.History of previous eye trauma or intraocular surgery. 5.Patients with systemic diseases who have surgical contraindications,missed follow-up.

研究实施时间:

Study execute time:

From 2024-12-31 00:00:00 To 2025-06-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-12-31 00:00:00 To 2025-02-28 00:00:00  

干预措施:

Interventions:

组别:

观察组。

样本量:

100

Group:

Observation group.

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

重庆 

市(区县):

 

Country:

China 

Province:

Chongqing 

City:

 

单位(医院):

中国人民解放军陆军特色医学中心 

单位级别:

三级甲等 

Institution
hospital:

Army Medical Center of PLA

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

视力

指标类型:

主要指标

Outcome:

vision

Type:

Primary indicator

测量时间点:

术前、术后1月、术后3月

测量方法:

标准视力表进行视力检查

Measure time point of outcome:

Before surgery,1m and 3m after surgery

Measure method:

Perform a visual acuity test using a standard visual acuity chart

指标中文名:

离焦曲线

指标类型:

主要指标

Outcome:

Defocus curve

Type:

Primary indicator

测量时间点:

术后3月

测量方法:

通过在眼前添加不同度数的镜片,将添加镜片的度数作为横坐标,将此度数下的视力作为纵坐标,描记而成的曲线就是离焦曲线。

Measure time point of outcome:

3m after surgery

Measure method:

The defocus curve is formed by adding lenses of different degrees in front of the eyes, with the degree of the added lenses as the horizontal axis and the visual acuity at this degree as the vertical axis.

指标中文名:

术后满意度调查

指标类型:

主要指标

Outcome:

Postoperative satisfaction survey

Type:

Primary indicator

测量时间点:

术后3月

测量方法:

调查问卷形式评分。

Measure time point of outcome:

3m after surgery

Measure method:

Scoring in the form of a survey questionnaire.

指标中文名:

客观视觉质量

指标类型:

次要指标

Outcome:

Objective visual quality

Type:

Secondary indicator

测量时间点:

术后3月

测量方法:

客观视觉质量测量仪器。

Measure time point of outcome:

3m after surgery

Measure method:

Objective visual quality measurement instrument.

指标中文名:

角膜内皮细胞计数

指标类型:

次要指标

Outcome:

Corneal endothelial cell count

Type:

Secondary indicator

测量时间点:

术前

测量方法:

角膜内皮镜计数

Measure time point of outcome:

Before surgery

Measure method:

Specular microscope

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

CRF

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2024-12-19 17:42:40